Lilja Anders 4
4 · HOOKIPA Pharma Inc. · Filed Apr 24, 2019
Insider Transaction Report
Form 4
Lilja Anders
Sr. VP, Technical Development
Transactions
- Award
Stock Option (Right to Buy)
2019-04-17+42,784→ 42,784 totalExercise: $14.00Exp: 2029-04-17→ Common Stock (42,784 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on April 17, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.